| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.25 | 0.3 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |